Recombinant human interleukin-10 (rHuIL-10) therapy in steroid-refractory chronic active Crohn's disease (CACD): Induction of neopterin, a degradation product of the pteridine pathway regulated by interferon-gamma*
References (0)
Cited by (0)
- *
This research was supported by Schering-Plough Research Institute, Kenilworth, NJ
Copyright © 1998 Published by Elsevier Inc.